"Serious" adverse events reported for ephedrine supplements in 1-5 mg range -- FDA.
This article was originally published in The Tan Sheet
"SERIOUS" ADVERSE REACTIONS REPORTED FOR EPHEDRINE SUPPLEMENTS IN 1-5 MG RANGE, FDA Office of Special Nutritionals Clinical Research and Review Staff Director Lori Love, MD/PhD, told the Food Advisory Committee at its Aug. 27-28 meeting in Washington, D.C. The low-dose adverse events were found in an analysis of approximately 603 adverse event reports on ephedra-containing products collected by FDA, Love explained.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC